Artos offers an AI-powered platform specifically designed for document creation and management in the life sciences sector, catering to the needs of both startups and large pharmaceutical companies. The platform provides a comprehensive suite of features that streamline the entire document lifecycle, from drafting to quality control. It supports the creation of essential regulatory documents such as Investigational New Drug applications (INDs), Non-Disclosure Agreements (NDAs), and Biologics License Applications (BLAs). By leveraging reliable AI developed by cross-functional experts, Artos ensures that the drafting process is efficient and accurate, allowing teams to focus on higher-level tasks while maintaining compliance with industry standards.

In addition to document drafting, Artos enhances clinical operations through tools that facilitate trial design, site management, and document management. The platform includes features like Inconsistency Intelligence, which allows for quick updates across protocols, and powerful search capabilities that enable users to compare existing protocols and access relevant data seamlessly. Artos is built to improve productivity and reduce costs, making it particularly beneficial for biotech companies operating under tight timelines and budgets. By automating various processes and providing intuitive workflows, Artos helps organizations optimize their operations and maintain data integrity throughout the document management process.

United States

Artos helps clinical development and medical writing teams turn their data into regulatory submissions in days instead of weeks. 

Life sciences companies spend $13 billion and millions of man-hours each year on regulatory submissions for health agencies. At Artos, we build AI and software tools to shrink those timelines so that life-saving treatments can get to patients sooner. 

Artos

Company Details